z-logo
open-access-imgOpen Access
Hemostatic system changes predictive value in patients with ischemic brain disorders
Author(s) -
R Raicević,
A Jovicić,
Slavka Mandić-Radić,
Dragana Djordjevic,
B Magdić,
Ljubo Marković,
D Veljancić,
Evica Dinčić,
Slobodan Obradović
Publication year - 2002
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0204377r
Subject(s) - partial thromboplastin time , fibrinolysis , d dimer , medicine , predictive value , gastroenterology , antithrombin , platelet , hemostasis , cardiology , heparin
The aim of this research was to determine the importance of tracking the dynamics of changes of the hemostatic system factors (aggregation of thrombocytes, D-dimer, PAI-1, antithrombin III, protein C and protein S, factor VII and factor VIII, fibrin degradation products, euglobulin test and th activated partial thromboplastin time--aPTPV) in relation to the level of the severity of ischaemic brain disorders (IBD) and the level of neurological and functional deficiency in the beginning of IBD manifestation from 7 to 10 days, 19 to 21 day, and after 3 to 6 months. The research results confirmed significant predictive value of changes of hemostatic system with the predomination of procoagulant factors, together with the insufficiency of fibrinolisys. Concerning the IBD severity and it's outcome, the significant predictive value was shown in the higher levels of PAI-1 and the lower level of antithrombin III, and borderline significant value was shown in the accelerated aggregation of thrombocytes and the increased concentration of D-dimer. It could be concluded that the tracking of the dynamics of changes in parameters of hemostatic system proved to be an easily accessible method with the significant predictive value regarding the development of more severe. IBD cases and the outcome of the disease itself.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here